Insider filing report for Changes in Beneficial Ownership
- Schedule 13G & 13D forms are used to report a party's ownership of stock which exceeds 5% of a company's total stock issue.
- Schedule 13G is a shorter version of Schedule 13D with fewer reporting requirements.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13D
(Amendment No. 1)
Under the Securities Exchange Act of 1934
Streamline Health Solutions Inc.
(Name of Issuer)
Common Stock, $0.01 par value
(Title of Class of Securities)
86323X106
(CUSIP Number)
Melissa Dehn
305 SE Chkalov Dr., Suite 111-322
Vancouver, WA 98683
(360) 737-4153
(Name, Address and Telephone Number of Person
Authorized to Receive Notices and Communications)
03/02/2021
(Date of Event which Requires
Filing of this Statement)
If the filing person has previously filed a statement on
Schedule 13G to report the acquisition which is the subject of
this Schedule 13D, and is filing this schedule because of
240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following
box. [X].
Note: Schedules filed in paper format shall include a signed
original and five copies of the schedule, including all
exhibits. See 240.13d-7 for other parties to whom copies are to
be sent.
*The remainder of this cover page shall be filled out for a
reporting person's initial filing on this form with respect to
the subject class of securities, and for any subsequent
amendment containing information which would alter the
disclosures provided in a prior cover page.
The information required in the remainder of this cover page
shall not be deemed to be "filed" for the purpose of Section 18
of the Securities Exchange Act of 1934 ("Act") or otherwise
subject to the liabilities of that section of the Act but shall
be subject to all other provisions of the Act (however, see the
Notes).
CUSIP No. 86323X106 SCHEDULE 13D Page 2 of 10
1 Name of Reporting Person
Justin J. Ferayorni
IRS Identification No. of Above Person
(entities only)
2 Check the Appropriate Box if a Member of a Group* (a) [ ]
(b) [ ]
3 SEC USE ONLY
4 Source of Funds WC
5 Check Box if Disclosure of Legal Proceedings
is Required Pursuant to Items 2(d) or 2(e) [ ]
6 Citizenship or Place of Organization
United States Citizen
NUMBER OF 7 Sole Voting Power 5,036,063
SHARES
BENEFICIALLY 8 Shared Voting Power -0-
OWNED BY EACH
REPORTING 9 Sole Dispositive Power 5,036,063
PERSON
WITH 10 Shared Dispositive Power -0-
11 Aggregate Amount Beneficially Owned by Each Reporting
Person
5,036,063
12 Check Box if the Aggregate Amount in Row 11 Excludes
Certain Shares
[ ]
13 Percent of Class Represented by Amount in Row 11
12.1%
14 Type of Reporting Person
IN
CUSIP No. 86323X106 SCHEDULE 13D Page 3 of 10
1 Name of Reporting Person
Tamarack Capital GP, LLC
IRS Identification No. of Above Person 47-4492240
(entities only)
2 Check the Appropriate Box if a Member of a Group* (a) [ ]
(b) [ ]
3 SEC USE ONLY
4 Source of Funds WC
5 Check Box if Disclosure of Legal Proceedings
is Required Pursuant to Items 2(d) or 2(e) [ ]
6 Citizenship or Place of Organization
Delaware
NUMBER OF 7 Sole Voting Power 4,930,882
SHARES
BENEFICIALLY 8 Shared Voting Power -0-
OWNED BY EACH
REPORTING 9 Sole Dispositive Power 4,930,882
PERSON
WITH 10 Shared Dispositive Power -0-
11 Aggregate Amount Beneficially Owned by Each Reporting
Person
4,930,882
12 Check Box if the Aggregate Amount in Row 11 Excludes
Certain Shares
[ ]
13 Percent of Class Represented by Amount in Row 11
11.8%
14 Type of Reporting Person
HC
CUSIP No. 86323X106 SCHEDULE 13D Page 4 of 10
1 Name of Reporting Person
Tamarack Advisers, LP
IRS Identification No. of Above Person 47-4492240
(entities only)
2 Check the Appropriate Box if a Member of a Group* (a) [ ]
(b) [ ]
3 SEC USE ONLY
4 Source of Funds WC
5 Check Box if Disclosure of Legal Proceedings
is Required Pursuant to Items 2(d) or 2(e) [ ]
6 Citizenship or Place of Organization
Delaware
NUMBER OF 7 Sole Voting Power 4,930,882
SHARES
BENEFICIALLY 8 Shared Voting Power -0-
OWNED BY EACH
REPORTING 9 Sole Dispositive Power 4,930,882
PERSON
WITH 10 Shared Dispositive Power -0-
11 Aggregate Amount Beneficially Owned by Each Reporting
Person
4,930,882
12 Check Box if the Aggregate Amount in Row 11 Excludes
Certain Shares
[ ]
13 Percent of Class Represented by Amount in Row 11
11.8%
14 Type of Reporting Person
IA
CUSIP No. 86323X106 SCHEDULE 13D Page 5 of 10
1 Name of Reporting Person
Tamarack Capital Management, LLC
IRS Identification No. of Above Person 90-0292676
(entities only)
2 Check the Appropriate Box if a Member of a Group* (a) [ ]
(b) [ ]
3 SEC USE ONLY
4 Source of Funds WC
5 Check Box if Disclosure of Legal Proceedings
is Required Pursuant to Items 2(d) or 2(e) [ ]
6 Citizenship or Place of Organization
Delaware
NUMBER OF 7 Sole Voting Power 4,930,882
SHARES
BENEFICIALLY 8 Shared Voting Power -0-
OWNED BY EACH
REPORTING 9 Sole Dispositive Power 4,930,882
PERSON
WITH 10 Shared Dispositive Power -0-
11 Aggregate Amount Beneficially Owned by Each Reporting
Person
4,930,882
12 Check Box if the Aggregate Amount in Row 11 Excludes
Certain Shares
[ ]
13 Percent of Class Represented by Amount in Row 11
11.8%
14 Type of Reporting Person
HC
CUSIP No. 86323X106 SCHEDULE 13D Page 6 of 10
1 Name of Reporting Person
Tamarack Global Healthcare Fund, L.P.
IRS Identification No. of Above Person 20-8297742
(entities only)
2 Check the Appropriate Box if a Member of a Group* (a) [ ]
(b) [ ]
3 SEC USE ONLY
4 Source of Funds WC
5 Check Box if Disclosure of Legal Proceedings
is Required Pursuant to Items 2(d) or 2(e) [ ]
6 Citizenship or Place of Organization
Delaware
NUMBER OF 7 Sole Voting Power 4,223,334
SHARES
BENEFICIALLY 8 Shared Voting Power -0-
OWNED BY EACH
REPORTING 9 Sole Dispositive Power 4,223,334
PERSON
WITH 10 Shared Dispositive Power -0-
11 Aggregate Amount Beneficially Owned by Each Reporting
Person
4,223,334
12 Check Box if the Aggregate Amount in Row 11 Excludes
Certain Shares
[ ]
13 Percent of Class Represented by Amount in Row 11
10.1%
14 Type of Reporting Person
PN
CUSIP No. 86323X106 SCHEDULE 13D Page 7 of 10
Item 1. Security and Issuer
This Schedule 13D ("Schedule") relates to shares of Common
Stock, $0.01 par value (the "Common Stock"), of Streamline
Health Solutions Inc. (the "Issuer"). The principal executive
office of the Issuer is 11800 Amber Park Drive, Suite 125,
Atlanta, GA 30009.
Item 2. Identity and Background
This Schedule is filed on behalf of the following entities:
Justin John Ferayorni, a United States Citizen.
Tamarack Capital GP, LLC, a Delaware limited liability company
("Tamarack GP")
Tamarack Advisers, LP, a Delaware limited partnership("Tamarack
IA")
Tamarack Capital Management, LLC, a Delaware limited liability
company("Tamarack PFGP")
Tamarack Global Healthcare Fund, L.P., a Delaware limited
partnership("Tamarack GHF")
The business address of the reporting entities is 5050 Avenida
Encinas, Suite 360, Carlsbad, CA 92008.
Mr. Ferayorni's main occupation or employment is an investment
adviser representative with Tamarack Advisers, LP, a registered
investment adviser located at the address listed above.
Mr. Ferayorni is the sole owner of Tamarack GP, the general
partner of Tamarack IA, of which he also the sole limited
partner.
Mr. Ferayorni is the sole owner of Tamarack PFGP, the general
partner of Tamarack GHF.
Mr. Ferayorni has not, during the past five years, been
convicted of any criminal proceeding (excluding traffic
violations or similar misdemeanors).
None of the reporting entities have been a party to a civil
proceeding of a judicial or administrative body of competent
jurisdiction and as a result of such proceeding was or is
subject to a judgment, decree or final order enjoining future
violations of, or prohibiting or mandating activities subject
to, federal or state securities laws or finding any violation
with respect to such laws.
CUSIP No. 86323X106 SCHEDULE 13D Page 8 of 10
Item 3. Source and Amount of Funds or Other Consideration
Funds for the purchases of Common Stock were obtained from the
working capital of Tamarack GHF.
Item 4. Purpose of Transaction.
The purchases of Common Stock were made solely for investment
purposes. Depending upon market conditions and other factors,
the reporting entities may increase beneficial ownership of
securities of the Issuer, or alternatively, may dispose of some
or all of the securities of the Issuer that it beneficially
owns.
Item 5. Interest in Securities of the Issuer
(a),(b) Reference is made hereby to Items 7-11 and 13 of pages
2 through 6 of this Schedule, which Items are
incorporated by reference herein.
The calculation of percentage of beneficial ownership
in item 13 of pages 2 through 8 were derived from the
Issuer's Form 10-Q filed with the Securities and
Exchange Commission on December 10, 2020, in which
The Issuer stated that the number of shares of Common
Stock outstanding as of December 8, 2020 was
31,663,210 and from the Issuer's Form 8-K filed with
the Securities and Exchange Commission on March 4,
2021, in which The Issuer stated that the number of
shares of Common Stock outstanding was increased by
10,062,500 shares for a total of 41,725,710 shares.
(c) The reporting entities acquired beneficial ownership
over the following stock in the last sixty days, as
part of their regular investment activities using
FINRA registered broker-dealers.
Date #of shares Price
---------------- ---------------- $-------------
03/02/2021 625,000 1.60
The above listed trades were effected by Tamarack GHF for which
Tamarack PFGP serves as general partner and Tamarack IA serves
as investment adviser in a private transaction using Craig-
Hallum Capital Group LLC as placement agent.
CUSIP No. 86323X106 SCHEDULE 13D Page 9 of 10
(d) No Other than the reporting persons, the additional
private fund, for which Tamarack PFGP serves as
general partner and Tamarack IA serves as investment
adviser, and the owners of the family accounts managed
by Mr. Ferayorni have the right to receive or the
power to direct the receipt of dividends from, or the
proceeds from, the sale of the common stock mentioned
in item 1.
(e) Not applicable.
Item 6. Contracts, Arrangements, Understandings or
Relationships with Respect to Securities of the Issuer
None.
Item 7. Material to be Filed as Exhibits
None.
Signatures
After reasonable inquiry and to the best of my knowledge and
belief, I certify that the information set forth in this
statement is true, complete and correct.
DATED: March 15, 2021
Justin J. Ferayorni
/s/ Justin J. Ferayorni
________________________
By: Justin J. Ferayorni
Its: Himself
Tamarack Capital GP, LLC
/s/ Justin J. Ferayorni
________________________
By: Justin J. Ferayorni
Its: Managing Member
Tamarack Advisers, LP
/s/ Justin J. Ferayorni
________________________
By: Justin J. Ferayorni
Its: Managing member of its general partner
Continued on next page
CUSIP No. 86323X106 SCHEDULE 13D Page 10 of 10
Signatures (continued)
Tamarack Capital Management, LLC
/s/ Justin J. Ferayorni
________________________
By: Justin J. Ferayorni
Its: Managing member
Tamarack Global Healthcare Fund, L.P.
/s/ Justin J. Ferayorni
________________________
By: Justin J. Ferayorni
Its: Managing member of its general partner